Les affections cardiaques liées à la COVID-19 : à propos de 101 cas
| dc.contributor.advisor | Khalid Ennibi | |
| dc.contributor.author | Ismail Nafi | |
| dc.date.accessioned | 2023-09-15T13:42:29Z | |
| dc.date.accessioned | 2026-01-22T13:34:16Z | |
| dc.date.available | 2023-09-15T13:42:29Z | |
| dc.date.issued | 2022 | |
| dc.description.collaborator | Yassir Bousliman | |
| dc.description.collaborator | Jaouad El Harti | |
| dc.description.collaborator | Yasmina Tadlaoui | |
| dc.identifier.uri | https://toubkalpreprod.imist.ma/handle/123456789/19241 | |
| dc.language.iso | fr | |
| dc.publisher | Université Mohammed 5 de Rabat, Faculté de Médecine et de Pharmacie, Rabat | fr_FR |
| dc.subject | COVID-19 | fr_FR |
| dc.subject | Sars-CoV-2 | fr_FR |
| dc.subject | complications cardiovasculaires | fr_FR |
| dc.subject | hydroxychloroquine | fr_FR |
| dc.subject.other | Sciences médicales | |
| dc.subject.specific | Sciences pharmaceutiques | |
| dc.title | Les affections cardiaques liées à la COVID-19 : à propos de 101 cas | fr_FR |
Files
Original bundle
1 - 1 of 1